Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Poolbeg Pharma announces expansion of POLB 001 into oncology

By: TheNewswire.com
ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.

Poolbeg Pharma PLC (AIM:POLB, OTCQB:POLBF) CEO Jeremy Skillington speaks to Proactive's Thomas Warner after announcing that the company has submitted a patent application for the use of POLB 001 in a new oncological indication. Skillington explains the reasons for the strategic expansion and reveals more about his vision for the molecule in the long term.

Contact Details

Proactive UK Ltd

+44 20 7989 0813

uk@proactiveinvestors.com

Report this content

If you believe this article contains misleading, harmful, or spam content, please let us know.

Report this article

Recent Quotes

View More
Symbol Price Change (%)
AMZN  254.08
-4.50 (-1.74%)
AAPL  342.96
+1.69 (0.50%)
AMD  570.82
-34.71 (-5.73%)
BAC  51.39
-2.57 (-4.76%)
GOOG  343.65
-5.87 (-1.68%)
META  737.54
-24.96 (-3.27%)
MSFT  533.69
-9.76 (-1.80%)
NVDA  221.30
-7.22 (-3.16%)
ORCL  130.55
-12.65 (-8.83%)
TSLA  367.16
-8.07 (-2.15%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.